A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Wave Life Sciences stock shot a year-high Monday on promising results for an entirely new mechanism that could target fat ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, researchers aren’t giving up yet.

GLP-1 RAs are safe and efficacious for adults with IBD, with no increased risk for flare-ups, hospitalization, corticosteroid use, or operation.

The new World Health Organization guideline supports using GLP-1 drugs for long-term obesity care, emphasizing lifestyle, behavioral therapy.

GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL ...

FGF19 triggers the brain to burn more energy and activate fat-burning cells, offering a potential new path for obesity ...

The abstract will be published in the peer-reviewed Metabolism: Experimental and Clinical. The presentation will be available on Biomea Fusion's Investor Relations Page under the Events. Please find a ...

Q3 2025 Earnings Call Transcript December 4, 2025 Operator: Good day, and thank you for standing by. Welcome to the Addex ...